Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Ridley

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
JAMA|April 20, 2016
Efficacy of the Priority Review Voucher ProgramDavid B Ridley, Jennifer Dent, Christopher Egerton-Warburton
Health Affairs (Project Hope)|August 9, 2017
A Voucher System To Speed Review Could Promote A New Generation Of Insecticides To Fight Vector-Borne DiseasesDavid B Ridley, Jeffrey L Moe, Nick Hamon
Health Affairs (Project Hope)|February 10, 2016
No Shot: US Vaccine Prices And ShortagesDavid B Ridley, Xiaoshu Bei, Eli B Liebman
Health Affairs (Project Hope)|August 2, 2021
​US Tropical Disease Priority Review Vouchers: Lessons In Promoting Drug Development And AccessDavid B Ridley, Pranav Ganapathy, Hannah E Kettler
Health Affairs (Project Hope)|December 4, 2023
FDA Global Drug Inspections: Surveillance Of Manufacturing Establishments Remains Well Below Pre-COVID-19 LevelsEmily Cuddy, Yun Peng Lu, David B Ridley
Health Affairs (Project Hope)|March 9, 2006
Developing drugs for developing countriesDavid B Ridley, Henry G Grabowski, Jeffrey L Moe
Journal of Health Economics|October 19, 2023
Consequences of a shortage and rationing: Evidence from a pediatric vaccineEli Liebman, Emily C Lawler, Abe Dunn, et al.
Journal of Health Care Finance|September 12, 2003
The cost of inefficiency in US hospitals, 1985-1997Bimal R Shah, Shelby D Reed, Jennifer Francis, et al.
Health Affairs (Project Hope)|March 9, 2006
Spending on postapproval drug safetyDavid B Ridley, Judith M Kramer, Hugh H Tilson, et al.
Medical Care|August 5, 2016
Real-World Data: Policy Issues Regarding their Access and UseAnirban Basu, Kirsten Axelsen, David C Grabowski, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
JAMA|April 20, 2016
Efficacy of the Priority Review Voucher ProgramDavid B Ridley, Jennifer Dent, Christopher Egerton-Warburton
Health Affairs (Project Hope)|August 9, 2017
A Voucher System To Speed Review Could Promote A New Generation Of Insecticides To Fight Vector-Borne DiseasesDavid B Ridley, Jeffrey L Moe, Nick Hamon
Health Affairs (Project Hope)|February 10, 2016
No Shot: US Vaccine Prices And ShortagesDavid B Ridley, Xiaoshu Bei, Eli B Liebman
Health Affairs (Project Hope)|August 2, 2021
​US Tropical Disease Priority Review Vouchers: Lessons In Promoting Drug Development And AccessDavid B Ridley, Pranav Ganapathy, Hannah E Kettler
Health Affairs (Project Hope)|December 4, 2023
FDA Global Drug Inspections: Surveillance Of Manufacturing Establishments Remains Well Below Pre-COVID-19 LevelsEmily Cuddy, Yun Peng Lu, David B Ridley
Health Affairs (Project Hope)|March 9, 2006
Developing drugs for developing countriesDavid B Ridley, Henry G Grabowski, Jeffrey L Moe
Journal of Health Economics|October 19, 2023
Consequences of a shortage and rationing: Evidence from a pediatric vaccineEli Liebman, Emily C Lawler, Abe Dunn, et al.
Journal of Health Care Finance|September 12, 2003
The cost of inefficiency in US hospitals, 1985-1997Bimal R Shah, Shelby D Reed, Jennifer Francis, et al.
Health Affairs (Project Hope)|March 9, 2006
Spending on postapproval drug safetyDavid B Ridley, Judith M Kramer, Hugh H Tilson, et al.
Medical Care|August 5, 2016
Real-World Data: Policy Issues Regarding their Access and UseAnirban Basu, Kirsten Axelsen, David C Grabowski, et al.
Pageof 3